SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-002970
Filing Date
2018-01-09
Accepted
2018-01-09 16:54:44
Documents
1
Period of Report
2018-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4194
  Complete submission text file 0001209191-18-002970.txt   5582
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
MOTT DAVID M (Reporting) CIK: 0001219871 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37569 | Film No.: 18519617

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Issuer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
SIC: 2834 Pharmaceutical Preparations